People & Technology Partners with Choice Technology for Development of Customized Infection Control Solutions
- AuthorElodie
- DateDec 31, 2024
- Views316
November 16, 2021 –
People & Technology, a leader in IoMT and medical AI, has signed a partnership agreement with Choice Technology as part of the Infection Control Equipment Technology Development Project announced by the Ministry of SMEs and Startups. The collaboration focuses on the development, clinical testing, and commercialization of wearable oxygen saturation monitoring devices and an AI monitoring system tailored to the needs of infection control sites.
Addressing Critical Needs in Respiratory Infection Control
For respiratory infections, continuous monitoring, recording, and analysis of blood oxygen saturation—a key indicator for severe cases—requires robust infrastructure. This includes wearable devices, real-time biometric monitoring, and integration with nurse stations and medical personnel dashboards for effective response.
Key Features of the Project
The partnership aims to deliver:
Affordable Wearable Device with Long-Lasting Functionality
- Development of a small, detachable probe device capable of continuous oxygen saturation measurement for more than five days per use.
Non-Contact IoMT Integration
- Creation of wireless data compatibility standards for seamless integration with IoMT systems, ensuring non-contact and remote operation.
AI-Driven Early Detection and Alerts
- Development of an AI algorithm to detect early signs of severe respiratory complications, providing accurate alerts for emergency situations.
Real-Time Monitoring and Alerts for Medical Staff
- Implementation of a system that offers real-time analysis, predictive insights, and emergency alerts for blood oxygen levels.
Clinical Testing and Regulatory Approval
- Conduct clinical trials in healthcare settings to evaluate prototype performance, followed by regulatory approval from the Korea Food and Drug Administration (KFDA).
_14828.png "%E1%84%8B%E1%85%B0%E1%84%8B%E1%85%A5%E1%84%85%E1%85%A5%E1%84%87%E1%85%B3%E1%86%AF%E1%84%89%E1%85%A1%E1%86%AB%E1%84%89%E1%85%A9%E1%84%91%E1%85%A9%E1%84%92%E1%85%AA%E1%84%83%E1%85%A9%E1%84%8E%E1%85%B3%E1%86%A8%E1%84%8C%E1%85%A5%E1%86%BC%E1%84%89%E1%85%B5%E1%84%89%E1%85%B3%E1%84%90%E1%85%A6%E1%86%B7-495x400%20(1)_14828.png")
Innovative Contributions to Infection Control
Aligned with the goals of the project and backed by mentoring from medical experts and experience in similar initiatives, the solution will focus on:
- Real-Time, Continuous Measurement: Providing uninterrupted oxygen saturation monitoring.
- Extended Usability: Ensuring devices can be used for a minimum of five days without interruption.
- Proactive Detection and Monitoring: Enabling early prediction and tracking of disease progression to severe stages.
- Cost-Effectiveness: Offering affordable solutions to meet infection control demands.
This initiative is set to revolutionize infection control protocols for respiratory diseases by providing a scalable, reliable, and cost-effective solution tailored to real-world healthcare needs. Through this partnership, People & Technology and Choice Technology aim to establish leadership in the field of non-contact, infection control medical devices.
